Phase II Clinical Development of New Drugs (Hardcover, 1st ed. 2017)

, , ,
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.

R3,885

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles38850
Mobicred@R364pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Springer Verlag, Singapore

Country of origin

Singapore

Series

ICSA Book Series in Statistics

Release date

April 2017

Availability

Expected to ship within 12 - 17 working days

First published

2017

Authors

, , ,

Dimensions

235 x 155 x 16mm (L x W x T)

Format

Hardcover

Pages

241

Edition

1st ed. 2017

ISBN-13

978-981-10-4192-1

Barcode

9789811041921

Categories

LSN

981-10-4192-X



Trending On Loot